$QREE
QUANTUM ENERGY INC.

2020 Q4 Form 10-Q Financial Statement

#000143774921013725 Filed on May 28, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q1 2019 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00 $0.00 $60.00K
YoY Change -100.0% -100.0% 100.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.854K $0.00 $56.15K
YoY Change -91.35% -100.0% 63.22%
Operating Profit -$4.854K
YoY Change
Interest Expense $7.058K -$30.00K $6.180K
YoY Change 14.21% 1327.25%
% of Operating Profit
Other Income/Expense, Net $225.6K $0.00 $21.07K
YoY Change 971.1% -4964.9%
Pretax Income $220.8K -$180.0K -$35.08K
YoY Change -729.34% 100.0% 0.71%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $220.8K -$180.0K -$35.08K
YoY Change -729.34% 100.0% 0.71%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.68 -$0.57 -$0.11
COMMON SHARES
Basic Shares Outstanding 48.49M 48.49M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $10.00K
YoY Change -100.0% 0.0%
Cash & Equivalents $47.00 $47.00 $9.095K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $47.00 $47.00 $1.578K
YoY Change -97.02% -97.02% -84.22%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $150.0K
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $0.00 $0.00 $7.822K
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $47.00 $47.00 $1.578K
Total Long-Term Assets $0.00 $0.00 $7.822K
Total Assets $47.00 $47.00 $9.400K
YoY Change -99.5% -99.5% -6.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $350.0K $320.0K $310.0K
YoY Change 12.9% 28.0% 93.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $250.0K $250.0K $260.0K
YoY Change -3.85% 257.14% 271.43%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $960.8K $912.7K $323.8K
YoY Change 196.72% 181.88% 40.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $960.8K $912.7K $323.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $960.8K $912.7K $323.8K
YoY Change 196.72% 181.88% 40.78%
SHAREHOLDERS EQUITY
Retained Earnings -$12.46M -$12.41M -$11.36M
YoY Change 9.68% 9.26%
Common Stock $48.49K $48.49K $48.49K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$960.7K -$912.7K -$728.6K
YoY Change
Total Liabilities & Shareholders Equity $47.00 $47.00 $9.400K
YoY Change -99.5% -99.5% -6.0%

Cashflow Statement

Concept 2020 Q4 2020 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income $220.8K -$180.0K -$35.08K
YoY Change -729.34% 100.0% 0.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00 -$130.0K
YoY Change -100.0% 62.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$150.0K
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$150.0K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -10.00K 290.0K
YoY Change -100.0% 314.29%
NET CHANGE
Cash From Operating Activities 0.000 0.000 -130.0K
Cash From Investing Activities 0.000 0.000 -150.0K
Cash From Financing Activities 0.000 -10.00K 290.0K
Net Change In Cash 0.000 -10.00K 10.00K
YoY Change -100.0% -200.0%
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 -$130.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 qegy Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.19
qegy Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
CY2020 qegy Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
1129802
qegy Class Of Warrant Or Right Cancelled During Period Exercise Price
ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice
CY2020 qegy Class Of Warrant Or Right Cancelled During Period Exercise Price
ClassOfWarrantOrRightCancelledDuringPeriodExercisePrice
CY2020Q4 qegy Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
3925000
qegy Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
CY2020 qegy Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
qegy Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
CY2020 qegy Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
qegy Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
CY2020 qegy Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
2925000
qegy Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
QUANTUM ENERGY INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001295961
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48491485
dei Trading Symbol
TradingSymbol
qegy
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Shell Company
EntityShellCompany
false
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Period End Date
DocumentPeriodEndDate
2020-11-30
dei Document Type
DocumentType
10-Q
dei Security12b Title
Security12bTitle
Common stock, $0.001 Par Value
qegy Class Of Warrant Or Right Remaining Term
ClassOfWarrantOrRightRemainingTerm
P306D
CY2020Q4 qegy Common Stock Payable Noncurrent
CommonStockPayableNoncurrent
200000
CY2020Q1 qegy Common Stock Payable Noncurrent
CommonStockPayableNoncurrent
200000
CY2020Q4 qegy Common Stock Voting Rights Number Of Votes Per Share
CommonStockVotingRightsNumberOfVotesPerShare
1
CY2020Q4 qegy Costs And Expenses Net Of Income
CostsAndExpensesNetOfIncome
220773
CY2019Q4 qegy Costs And Expenses Net Of Income
CostsAndExpensesNetOfIncome
-35080
qegy Costs And Expenses Net Of Income
CostsAndExpensesNetOfIncome
48043
qegy Costs And Expenses Net Of Income
CostsAndExpensesNetOfIncome
-867505
qegy Deposits Written Off
DepositsWrittenOff
qegy Deposits Written Off
DepositsWrittenOff
7822
qegy Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
15000
qegy Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
-516
qegy Interest Expense On Default Of Convertible Note
InterestExpenseOnDefaultOfConvertibleNote
qegy Interest Expense On Default Of Convertible Note
InterestExpenseOnDefaultOfConvertibleNote
22500
qegy Interest Expense Warrants
InterestExpenseWarrants
qegy Interest Expense Warrants
InterestExpenseWarrants
453261
CY2020Q4 qegy Interest Expense Warrants
InterestExpenseWarrants
CY2019Q4 qegy Interest Expense Warrants
InterestExpenseWarrants
CY2020Q4 qegy Managements Fees And Compensation
ManagementsFeesAndCompensation
CY2019Q4 qegy Managements Fees And Compensation
ManagementsFeesAndCompensation
qegy Managements Fees And Compensation
ManagementsFeesAndCompensation
qegy Managements Fees And Compensation
ManagementsFeesAndCompensation
11750
qegy Proceeds From Stock Subscription
ProceedsFromStockSubscription
qegy Proceeds From Stock Subscription
ProceedsFromStockSubscription
200000
CY2020Q4 qegy Promissory Notes Payable Current
PromissoryNotesPayableCurrent
76305
CY2020Q1 qegy Promissory Notes Payable Current
PromissoryNotesPayableCurrent
76305
CY2019Q4 qegy Value Of Subscription Receivable
ValueOfSubscriptionReceivable
200000
qegy Value Of Subscription Receivable
ValueOfSubscriptionReceivable
200000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
158959
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
147888
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
191837
CY2020Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
176837
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11449681
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11449681
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
453261
CY2020Q4 us-gaap Assets
Assets
47
CY2020Q1 us-gaap Assets
Assets
47
CY2020Q4 us-gaap Assets Current
AssetsCurrent
47
CY2020Q1 us-gaap Assets Current
AssetsCurrent
47
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
495000000
CY2020Q4 us-gaap Cash
Cash
47
CY2020Q1 us-gaap Cash
Cash
47
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1578
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9095
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7517
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3925000
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3925000
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2129802
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3925000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
495000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48491485
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48491485
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48491485
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48491485
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
48491
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
48491
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
67500
CY2020Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
67500
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
CY2020Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
160157
CY2020Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
138185
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
232685
CY2019Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
27245
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-21972
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-114736
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1684
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34555
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
220773
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35080
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48043
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-867505
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11071
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
57205
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
30000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3925000
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3925000
CY2020Q4 us-gaap Interest Expense
InterestExpense
7058
CY2019Q4 us-gaap Interest Expense
InterestExpense
6180
us-gaap Interest Expense
InterestExpense
21217
us-gaap Interest Expense
InterestExpense
38385
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2020Q4 us-gaap Liabilities
Liabilities
960773
CY2020Q1 us-gaap Liabilities
Liabilities
912730
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
960773
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
912730
CY2020Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
CY2019Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
888
us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font: inherit;">1</div> - NATURE OF OPERATIONS</div></div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">QUANTUM ENERGY INC. (&#x201c;the Company&#x201d;) was incorporated under the name &#x201c;Boomers Cultural Development Inc.&#x201d; under the laws of the State of Nevada on <div style="display: inline; font-style: italic; font: inherit;"> February 5, 2004. </div>On <div style="display: inline; font-style: italic; font: inherit;"> May 18, 2006, </div>the Company changed its name to Quantum Energy, Inc.</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is a development stage diversified holding company with an emphasis in land holdings, refinery and fuel distribution.</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is domiciled in the Unites States of America and trades on the OTC market under the symbol QEGY.</div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
370014
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-212497
us-gaap Net Income Loss
NetIncomeLoss
-48043
us-gaap Net Income Loss
NetIncomeLoss
-867505
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-35080
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
220773
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-35080
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
225627
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21065
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43189
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-636382
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
76305
CY2020Q1 us-gaap Notes Payable Current
NotesPayableCurrent
76305
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
106015
CY2020Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
106015
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
4854
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
56145
us-gaap Operating Expenses
OperatingExpenses
4854
us-gaap Operating Expenses
OperatingExpenses
231123
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
150000
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
45000
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
125000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
93299
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31715
CY2020Q4 us-gaap Professional Fees
ProfessionalFees
4854
CY2019Q4 us-gaap Professional Fees
ProfessionalFees
54461
us-gaap Professional Fees
ProfessionalFees
4854
us-gaap Professional Fees
ProfessionalFees
183930
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
30000
CY2020Q4 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
CY2019Q4 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12458898
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12410855
CY2018 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
833333
CY2018Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
10000000
CY2018Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-960726
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-912683
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-893560
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-728640
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1181498
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-314396
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div>
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3925000
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3925000
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48491485
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48491485
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48491485
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48491485

Files In Submission

Name View Source Status
0001437749-21-013725-index-headers.html Edgar Link pending
0001437749-21-013725-index.html Edgar Link pending
0001437749-21-013725.txt Edgar Link pending
0001437749-21-013725-xbrl.zip Edgar Link pending
ex_227126.htm Edgar Link pending
ex_227127.htm Edgar Link pending
ex_227128.htm Edgar Link pending
ex_227129.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
qegy-20201130.xml Edgar Link completed
qegy-20201130.xsd Edgar Link pending
qegy-20201130_cal.xml Edgar Link unprocessable
qegy-20201130_def.xml Edgar Link unprocessable
qegy-20201130_lab.xml Edgar Link unprocessable
qegy-20201130_pre.xml Edgar Link unprocessable
qegy20201130_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending